Clinical Trials Directory

Trials / Completed

CompletedNCT01702025

Rapid Acclimatization to Hypoxia at Altitude

Status
Completed
Phase
Phase 1 / Phase 2
Study type
Interventional
Enrollment
41 (actual)
Sponsor
Colorado State University · Academic / Other
Sex
All
Age
18 Years – 40 Years
Healthy volunteers
Accepted

Summary

In low oxygen environments, such as altitude, some adults may become ill and suffer from acute mountain sickness. Further, all adults will find that exercising becomes much more difficult when compared with exercise at lower altitudes (e.g. sea-level). The purpose of this investigation is to study the effects of two drugs that may help people adjust to high-altitude quickly, prevent them from becoming ill and improve their exercise performance. The drugs are Methazolamide and Aminophylline.

Conditions

Interventions

TypeNameDescription
DRUGPlaceboYellow corn meal in gel capsules
DRUGAminophyllineNational Drug Code (NDC) 0143-1020-01
DRUGMethazolamideNDC 0781-1072-01
DRUGAminophylline+MethazolamideNDC 0143-1020-01 and NDC 0781-1072-01

Timeline

Start date
2012-06-01
Primary completion
2012-12-01
Completion
2012-12-01
First posted
2012-10-05
Last updated
2014-10-24
Results posted
2014-10-24

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT01702025. Inclusion in this directory is not an endorsement.